Prostatic Hyperplasia
|
Dendreon Presents Preclinical Data Demonstrating Activity Of Trp-p8 Agonist, D-3263, In Benign...
medicalnewstoday.com 6 hrs ago 6 related
Researchers from Dendreon Corporation (Nasdaq: DNDN) presented preclinical data demonstrating the potential of D-3263, Dendreon's orally bioavailable small molecule, which targets Trp-p8 (a transmembrane cation channel protein also known as Trp-M8), to treat benign prostatic hyperplasia (BPH).
Watson Reports Positive Phase III Data for Prostate and Bladder Drugs
redorbit.com 3 hrs ago 4 related
Watson Pharmaceuticals has announced positive data from clinical studies on two Phase III products - silodosin, an investigational treatment for benign prostatic hyperplasia and oxybutynin chloride topical gel, an investigational product for overactive bladder.
Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of the American...
drugs.com 3 hrs ago 4 related
MILAN, Italy, May 21, 2008 - BioXell S.p.A. (SWX: BXLN) today presents the data from its successful Phase IIb trial of Elocalcitol in BPH (Benign Prostatic Hyperplasia) in a podium presentation at the American Urological Association Annual... ... MILAN, Italy, May 21,...
Boeing CEO defends overseas suppliers
nwsource.com 12 hrs ago 9 related
Boeing Boeing CEO Jim McNerney on Wednesday defended the company's reliance on overseas suppliers in building its 787 jetliner despite admittedly "big stutter steps," saying the new plane's innovations give the company a five-year lead over rival Airbus. McNerney said Boeing's new strategy of...
How Do You Recognize The Symptoms Of Prostate Problems?
misterarticle.com 13 hrs ago
It may seem strange but for years most men knew little about their prostate and it is only in recent years as prostate cancer has gained in prominence that men are starting to ask just what the prostate is and what its function is. The prostate is a very important component of the male...
InPlay: Genvec receives grant for PEDF program (Briefing.com)
yahoo.com yesterday 20 related
7:37AM Charming Shoppes beats by $0.07, misses on revs; guides Q2 EPS below consensus, revs below consensus 5.64 : Reports Q1 (Apr) earnings of $0.01 per share, $0.07 better than the First Call consensus of ($0.06); revenues fell 7.9% year/year to $641.3 mln vs the $725.2 mln consensus. Co issues...
Protox to present BPH data at AUA Conference
newswire.ca May 20, 2008
VANCOUVER, May 20 /CNW/ - Protox Therapeutics Inc. (TSX:PRX), a leader in the development of receptor targeted fusion proteins, today announced that preliminary data from the Phase 1 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH), will be presented...
New analysis boosts drug's prostate cancer value
thestar.com.my May 20, 2008 33 related
WASHINGTON (Reuters) - The drug is finasteride, formerly sold by Merck and Co as Proscar to treat enlargement of the prostate and now available generically. When the initial results of the study were announced, the researchers cautioned that men in the study who developed prostate cancer while...
Buy Cardura
mister-wong.com May 18, 2008 4 related
Common uses This medicine is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia (bph). Before using Do not take this medicine if you are also taking certain medicines for erectile dysfunction such as sildenafil, tadalafil, or vardenafil. Do not start or stop any...
A River Runs Through It: Bladder Microphone Hears Your Prostate [Prostate Microphone]
gizmodo.com May 18, 2008 1 related
Catheters suck, but they're a necessary evil for men who want to know if they have benign prostatic hyperplasia (quickie Giz diagnosis: you're cancer-free, but pee six times an hour). And in addition to excrutiting tube-down-your-johnson pain, the catheter also carries with it the potential for...